Novo Nordisk A/SNVONYSE
Loading
Year-over-year earnings per share growth rate
Latest
34.67%
↑ 625% vs avg
Percentile
P90
Near historical high
Streak
1 qtr
Consecutive growthAccelerating
Average
4.78%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 34.67% |
| Q3 2025 | -24.50% |
| Q2 2025 | -8.87% |
| Q1 2025 | 3.15% |
| Q4 2024 | 3.43% |
| Q3 2024 | 36.22% |
| Q2 2024 | -21.05% |
| Q1 2024 | 15.85% |
| Q4 2023 | -1.99% |
| Q3 2023 | 15.94% |
| Q2 2023 | -1.59% |
| Q1 2023 | 45.70% |
| Q4 2022 | -4.73% |
| Q3 2022 | 8.19% |
| Q2 2022 | -5.79% |
| Q1 2022 | 30.67% |
| Q4 2021 | -10.19% |
| Q3 2021 | 0.76% |
| Q2 2021 | -4.01% |
| Q1 2021 | 36.32% |
| Q4 2020 | -9.05% |
| Q3 2020 | -2.64% |
| Q2 2020 | -10.63% |
| Q1 2020 | 37.30% |
| Q4 2019 | -13.95% |
| Q3 2019 | 6.44% |
| Q2 2019 | -7.76% |
| Q1 2019 | 24.43% |
| Q4 2018 | -5.88% |
| Q3 2018 | -12.21% |
| Q2 2018 | -3.62% |
| Q1 2018 | 32.34% |
| Q4 2017 | -15.66% |
| Q3 2017 | -1.49% |
| Q2 2017 | -1.47% |
| Q1 2017 | 17.92% |
| Q4 2016 | -10.82% |
| Q3 2016 | -1.52% |
| Q2 2016 | 5.91% |
| Q1 2016 | 15.53% |